August 2022 Recap: Drug Pipeline Update
Stay up-to-date on the latest drugs in development.
Stay up-to-date on the latest drugs in development.
The new ProvayBlue presentation is supplied in a box of five 10mL single-dose vials; each vial contains 50mg of methylene blue.
For patients with follicular lymphoma who do not experience a grade 3 or higher IRR during Cycle 1, Gazyva may now be administered as a 90-minute infusion.
Organization has had to limit blood product distributions to hospitals
Continued approval required further verification and description of clinical benefit in confirmatory trials.
The FDA extended the target dates for beti-cel and eli-cel to allow time to review additional clinical information for both applications.
People who have received COVID-19 vaccines can donate blood and platelets as long as they are symptom-free
NP10679 is an investigational subunit-specific NMDA receptor inhibitor.
Results showed an overall response rate of 84.8%.
Continued approval required further verification and description of clinical benefit in confirmatory trials.